"Covenant Health is the only integrated health network in the region dedicated to a Christian mission of healing by caring for the whole person – body, mind and spirit – and by working with others to improve health and quality of life in our communities. Among our offerings are numerous Centers of Excellence-areas in which we are leading the way to the future of health care."

During the past decade, Covenant Medical Center-Lakeside conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 21 clinical trials were completed, i.e. on average, 84% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 16 clinical trials were completed. i.e. 533.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Covenant Medical Center-Lakeside" #1 sponsor was "National Cancer Institute (NCI)" with 21 trials, followed by "SWOG Cancer Research Network" with 13 trials sponsored, "NRG Oncology" with 3 trials sponsored, "Cyberonics, Inc." with 2 trials sponsored and "NSABP Foundation Inc" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Covenant Medical Center-Lakeside" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Radiation Therapy Oncology Group" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "NCIC Clinical Trials Group" with 2 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Covenant Medical Center-Lakeside" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Stage IB Breast Cancer" (4 trials), "Recurrent Breast Carcinoma" (3 trials) and "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials). Many other conditions were trialed in "Covenant Medical Center-Lakeside" in a lesser frequency.

Most popular intervention types in "Covenant Medical Center-Lakeside" are "Drug" (40 trials), "Other" (37 trials), "Biological" (18 trials), "Radiation" (13 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (27 trials), "Quality-of-Life Assessment" (10 trials), "Docetaxel" (7 trials), "Biospecimen Collection" (6 trials) and "Cyclophosphamide" (6 trials). Other intervention names were less common.

The vast majority of trials in "Covenant Medical Center-Lakeside" are 43 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Covenant Medical Center-Lakeside". undefined are not yet recruiting, 8 are recruiting, 20 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Covenant Medical Center-Lakeside, 2 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Covenant Medical Center-Lakeside, 0 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".